Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.

Immunisation in a digital world - Futures Workshop

678 Aufrufe

Veröffentlicht am

On Tuesday, 26th June the International Longevity Centre - UK (ILC-UK) hosted a one-day Futures Workshop on immunisation in a digital world in Brussels.

The workshop hosted medical professionals, communications experts, policy makers and technological innovators to discuss how new technologies can help to improve adult immunisation and the barriers to implementation and uptake.

For more information visit http://www.ilcuk.org.uk/index.php/events/immunisation_in_a_digital_world_futures_workshop

Veröffentlicht in: Technologie
  • The Kidney Disease Solution EBOOK Download Link ★★★ https://tinyurl.com/y5392ufy
       Antworten 
    Sind Sie sicher, dass Sie …  Ja  Nein
    Ihre Nachricht erscheint hier
  • Gehören Sie zu den Ersten, denen das gefällt!

Immunisation in a digital world - Futures Workshop

  1. 1. Immunisation in a digital world: Futures Workshop Tuesday 26th June 2018 This event is kindly supported by Sanofi #ImmuTech
  2. 2. Welcome and plan for the workshop David Sinclair Director ILC-UK This event is kindly supported by Sanofi #ImmuTech
  3. 3. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. Welcome David Sinclair, International Longevity Centre – UK @ilcuk @sinclairda
  4. 4. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. The specialist think tank on the impact of longevity on society, and what happens next.
  5. 5. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. Our work on vaccination Working with and speaking at IFA events; Event on Vaccination and AMR; Immune Response Report; SAATI report; Spoken at events in London, Brussels, San Francisco, Barcelona etc; Spoken at Academic (e.g. ECCMID; IAGG) as well as policy (IFA). Ran vaccine related events at our conference. Worked with UK and European policy-makers; House of Lords dinners; Worked with All Party Vaccination Group and ABPI Group in Parliament; Event in European Parliament; Spoke to DH Vaccine officials in Australia; Maintained and promoted website; participated in Florence Geriatric conferences; articles in media (e.g. in the Guardian). Media stories about our work on vaccination. Mentioned adult vaccination on BBC Breakfast interview.
  6. 6. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. Welcome 10:00 Welcome/Plan for the workshop David Sinclair, Director, ILC-UK Why is adult immunisation important and what do we need to do to increase uptake? 10:10 Speeches and Panel discussion How might technology help break down the barriers to adult immunisation? 10:50 Speeches and Q&A Putting ourselves in the shoes of someone who isn’t vaccinated 12:15 Workshop - Why don’t adults get vaccinated 12:35 Lunch 13:05 Plan for the afternoon How can technology help? Futures Workshop 13:10 Playing Higher or lower, pt. I - Ideas for using technology All 13:25 Playing Higher or lower, pt. 2 - Barriers to using technology All 13:40 Playing higher or lower, pt. 3 - Policy and practical solutions to using technology All 13:55 Feedback “Why don’t adults get vaccinated?” and “Higher and Lower” All Conclusion 14:30 Speeches and reactions 16:00 Close All
  7. 7. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. What do we want from you today  Stand up; make coffee; swap groups if you want; tell us what you think.  An open mind! Have a look at the posters – Your ideas of how technology can increase uptake of adult immunisation – Your views on the barriers to the use of technology to increase uptake of adult vaccination – Your views on the policy change needed We will publish a final report in the autumn.
  8. 8. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. David Sinclair Director International Longevity Centre - UK Davidsinclair@ilcuk.org.uk 02073400440 Twitter: @ilcuk and @sinclairda
  9. 9. Why is adult immunisation important and what do we need to do to increase uptake? This event is kindly supported by Sanofi #ImmuTech
  10. 10. Elena Gentile MEP Group of the Progressive Alliance of Socialists and Democrats Italy This event is kindly supported by Sanofi #ImmuTech
  11. 11. Dave Eaton Policy and Public Affairs Manager ILC-UK This event is kindly supported by Sanofi #ImmuTech
  12. 12. Daphne Holt Chair Coalition for Life-Course Immunisation This event is kindly supported by Sanofi #ImmuTech
  13. 13. Peggy Maguire Director General European Institute of Women’s Health This event is kindly supported by Sanofi #ImmuTech
  14. 14. This event is kindly supported by Sanofi #ImmuTech
  15. 15. This event is kindly supported by Sanofi #ImmuTech
  16. 16. This event is kindly supported by Sanofi #ImmuTech
  17. 17. This event is kindly supported by Sanofi #ImmuTech
  18. 18. This event is kindly supported by Sanofi #ImmuTech
  19. 19. This event is kindly supported by Sanofi #ImmuTech
  20. 20. This event is kindly supported by Sanofi #ImmuTech
  21. 21. Dr Isabel De La Mata Barranco Principal Adviser for Health and Crisis Management DG Sante This event is kindly supported by Sanofi #ImmuTech
  22. 22. Q&A This event is kindly supported by Sanofi #ImmuTech
  23. 23. How might technology help break down the barriers to adult immunisation? This event is kindly supported by Sanofi #ImmuTech
  24. 24. How the UK used technology and data to maximise uptake of vaccination David Salisbury Centre on Global Health Security Chatham House This event is kindly supported by Sanofi #ImmuTech
  25. 25. Immunisation in a digital world. Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSci Centre on Global Health Security, Chatham House, London.
  26. 26. Immunisation data Process Coverage Outcome Sero- surveillance Disease surveillance Adverse reactions Immunisation Performance Indicators
  27. 27. Birth registration • Prompt • Ubiquitous Physician registration • Call / recall • Rapid upload Local/Regional / National • Data analysis • Performance management Immunisation coverage data
  28. 28. Influenza vaccination: data for management
  29. 29. Influenza vaccine uptake for those aged 65 and over and 65 at risk from 2000 to 2001 through to 2017 to 2018 for England. WHO 2010 target is 75%. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/710416/Seasonal_influenza_vaccine_uptake_in_GP_patients_winter_season_2017 _to_2018..pdf
  30. 30. Vaccine uptake in under 65s, by indication for vaccination and age, in 2010-2011 Begum, F. and R. Pebody, Seasonal influenza vaccine uptake amongst GP patient groups in England, Winter season 2010-11, 2011, Department of Health.
  31. 31. Flu mortality by risk group Source – HPA: Surveillance of influenza and other respiratory viruses in the UK 2010-2011
  32. 32. Universal childhood influenza vaccination
  33. 33. Impact of vaccination in 2014–2015: summary • Number needed to prevent by vaccinating children for the whole population impact – 16 children vaccination will prevent 1 GP ILI consultation – 317 children vaccination will prevent 1 influenza hospitalisation – 2205 children vaccination will prevent 1 confirmed influenza ICU/HDU admission. Primary school pilot areas versus non-pilot areas 39 Age group GP ILI consultations ED respiratory attendance Hospital admission ICU/HDU admission 5–10 years -94% OR 0.06 (0.01 – 0.62) ARD -247/100,000 popn -74% OR 0.26 (0.08 – 0.91) ARD - 9% -93% OR 0.07 (0.01 – 0.55) ARD -16/100,000 popn -76%* OR 0.24 (0.02 to 3.01) ARD -2/100,000 popn <5 years -92%* OR 0.08 (0.01 – 1.02) ARD -227/100,000 popn -65%* OR 0.35 (0.04 – 2.94) ARD - 16% -62%* OR 0.38 (0.11 – 1.32) ARD -31/100,000 popn -61%* OR 0.39 (0.06 to 2.55) ARD -3/100,000 popn >17 years -59% OR 0.41 (0.19 – 0.86) ARD -289/100,000 popn -21%* OR 0.79 (0.37 – 11.66) ARD - 1% -34%* OR 0.66 (0.22 – 11.93) ARD -14/100,000 popn -46%* OR 0.54 (0.25 to 1.16) ARD -2/100,000 popn ‘bold %’ p<0.05; * Statistically non significant; (%), confidence interval; ARD, absolute risk difference; popn, population ED, emergency department, GP, general practitioner, ILI, influenza-like illness, ICU, intensive care unit, HDU, high dependency unit ADAPTED from Pebody RG et al. Euro Surveill. 2015;20(39):pii=30029.
  34. 34. Immunisation – the intersection. StrategyPolicy Informatio n Systems Performance Management
  35. 35. How Big Data can address hurdles related to vaccination access & coverage Michael Greenberg, M.D., MPH Vice President and Head, Global Medical Strategy Sanofi Pasteur This event is kindly supported by Sanofi #ImmuTech
  36. 36. Addressing vaccination access & coverage through Big Data Sources: 1National Diabetes Statistics Report, 2014 (released June 10, 2014) http://www.diabetes.org/diabetes-basics/statistics/?loc=db-slabnav#sthash.GuDGFjln.dpuf. Accessed April 9, 2015 | 2Gregg EW et al. N Engl J Med 2014;370:1514-1523 | 3ational Institute of Diabetes and Kidney Diseases 2009 | MICRO-VASCULAR COMPLICATIONS FOR ENDORSEMENT Global Medical Strategy, Sanofi Pasteur Michael Greenberg, MD, MPH
  37. 37. 6 Million 48 Million 2 Billion 48 28
  38. 38. Volume SCALE OF DATA Variety DIFFERENT FORMS OF DATA Veracity UNCERTAINTY OF DATA Velocity ANALYSIS OF STREAMING DATA Thousands of publications Flu – 50 million flu queries weekly Daily behavior of >57 000 diabetic patients VAXITREND – Internal Market Researches 20 countries; 17 000 patients, 3000 HCPs The FOUR Vs Daily Behavior information Activity trackers Daily searches Graphs / Tables Internet queries & posts Publications Lifestyle Trackers Internal data controls Data cleaning GRADE Evaluation: Evaluate the quality of medical evidence Methodological rigor Why Big Data?
  39. 39. Why Flu & Diabetes? 45 We need deeper understanding to increase flu vaccine coverage HOSPITALIZATIONMetabolic complication: Decompensation, ketoacidosis , deaths Infection complication Secondary infection Influenza vaccination is recommended (and funded) DEATHS 3-6x 6x Why do people living with Diabetes do not get vaccinated (more)?
  40. 40. 3-Step pilot experimentation approach 46 • Scientific data review - make sure we don’t find what is already known • Using natural language processing, machine learning, deep learning • Design methodology for understanding patient behavioral phenotypes • Run small scale real-world pilots • Experience building a datamart that unites google, sanofi and publicly available data • Emphasis on country level implementation 1 2 3
  41. 41. 28/06/2018 47 EVIDATION: THE METHODOLOGY We conducted a retrospective study of influenza-related outcomes (IRO) among fully insured Type 2 diabetics from a large US payer over a 1 year period covering the 2016-17 influenza season. We used bivariate analyses (54,656 diabetics, mean age 54.8 yr, s.d. = 10.2) to compare IRO’s inferred from claims data against IRO’s for 113,016 age and gender matched non-diabetics. Samson S, Lee W et al. D Using Claims and Consumer Wearable Devices Data to Quantify Influenza-Related Outcomes among Type 2 Diabetes Patients—A Large Population Study [abstract]. ADA, Orlando, June 22, 2018.
  42. 42. 28/06/2018 48 EVIDATION: THE RESULTS
  43. 43. 28/06/2018 49 EVIDATION: THE RESULTS (2/2) Within 2-weeks before and 4- weeks after a medical claim for influenza, diabetics with influenza had more observed hyperglycemic events than in a comparable non- influenza period in the same year (p<0.001),
  44. 44. 28/06/2018 50 GOOGLE: METHODOLOGY We used VaxiTrends, a proprietary dataset, to identify variables influencing vaccine uptake among adults in the U.S., China, France, Mexico, and U.K. We combined the data with National Health Interview Survey results from the CDC, which offer insights into health behaviors of Americans with diabetes. This information was aggregated with data from Google FluTrend, which signals flu incidence, & Google Trends Application Programming Interface, which tracks search keyword popularity by location & date in a de-identified fashion. Cluster analyses indicated factors most positively & negatively associated with acceptance & adherence Liska, J, Gupta A et al. D Using Claims and Consumer Wearable Devices Data to Quantify Influenza-Related Outcomes among Type 2 Diabetes Patients—A Large Population Study [abstract]. ADA, Orlando, June 22, 2018.
  45. 45. GOOGLE: RESULTS 51 factors impacting flu vaccination vary by country for people living with diabetes Orderedintermsofimportance fromHighestinfluencertoLowest Negative Factors Positive Factors
  46. 46. 28/06/2018 52 GOOGLE: RESULTS Adherence Impact Calculator Google created a country specific dashboard for local users to identify behavioral drivers of flu vaccination & the most receptive subgroups to design tailored interventions to increase uptake
  47. 47. Access to the right data remains a barrier 53 Improved vaccine coverage estimates at finer level Individual, physician, pharmacy, workplace …not about personal data but better understanding
  48. 48. THANK YOU
  49. 49. WHAT do we aim at delivering and HOW? 55 … to generate end 2017 value from Medical to Business Operations 1) Augmented data value 2) Accelerated evidence generation 3) Simplicity and scale of insights 4) Actionable learnings for the business 5) Continuous insight and performance observation 1) Vaxitrend survey data for 2015 comprising of 5 countries (France, USA, UK, Mexico and China) 2) Combined with Google’s Trends and Flu Trends 3) … and NHIS* datasets 3 DATA SOURCES 5 DELIVERABLES *The National Health Interview Survey (NHIS) has monitored the health of the US nation since 1957. NHIS data on a broad range of health topics are collected through personal household interviews. November 8th 2017Flu & Diabetes – Google Pilot Advancement Status
  50. 50. China7 Quick win segment over clinical inertia 56 Insight: This group can be easily activated by a targeted campaign • High intent to vaccinate despite having zero adherence • Scared of catching flu • Takes action to protect themselves against flu • Seeks information about health issues China7 FOR ENDORSEMENTEARLY RESULTS – DRAFT VISUALISATIONS – WORK IN PROGRESS November 8th 2017Flu & Diabetes – Google Pilot Advancement Status China7 àQuick win segment over clinical inertia 8 Insight: This group can be easily activated by a targeted campaign • High intent to vaccinate despite having zero adherence • Scared of catching flu • Takes action to protect themselves against flu • Seeks information about health issues China7 FOR ENDORSEMENTEARLY RESULTS – DRAFT VISUALISATIONS – WORK IN PROGRESS November 8 th 2017Flu & Diabetes – Google Pilot Advancement Status
  51. 51. US3 Effort intensive segment for Higher Adherence 57 Insight: This group living with Diabetes should not be prioritized • No intent to Vaccinate • Issue with Accessibility • Not in favor of Vaccination • Don’t take flu job in spite of reminders • Think that they will not be vulnerable to flu. US3 FOR ENDORSEMENTEARLY RESULTS – DRAFT VISUALISATIONS – WORK IN PROGRESS November 8th 2017Flu & Diabetes – Google Pilot Advancement Status
  52. 52. Google Influenza Trends Offers Regional Granularity 58 In a single view adherence with respect to Geographical level. Search trends for both positive and negative terms are observed . November 8th 2017Flu & Diabetes – Google Pilot Advancement Status
  53. 53. KEY FACTORS IMPACTING FLU VACCINATION ADHERENCE… 59 … vary by country for people living with Diabetes Orderedintermsofimportance fromHighestinfluencertoLowest Negative Factors Positive Factors
  54. 54. Social Media and Immunisation Philip Weiss Chairman ZN Consulting This event is kindly supported by Sanofi #ImmuTech
  55. 55. https://prezi.com/r2rpwzixz7uk/fakenews-tweets-and-healthcare- brussels/ This event is kindly supported by Sanofi #ImmuTech
  56. 56. Local views and information on the current Italian communication & digital context Prof Pier Luigi Lopalco Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa This event is kindly supported by Sanofi #ImmuTech
  57. 57. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 LOCAL VIEWS AND INFORMATION ON THE CURRENT ITALIAN COMMUNICATION & DIGITAL CONTEXT Pier Luigi Lopalco 26 June 2018, Brussels
  58. 58. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 2009, flu pandemic 64 5 rules to better fight flu Pandemic flu is a normal flu
  59. 59. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 65 November 2014
  60. 60. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 66 Lethal injection
  61. 61. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 Immunization coverage >64 yrs 67Data source: Ministry of Health % Pandemic vaccination campaign “Fluad case”
  62. 62. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 68 Rimini’s Court: “Measles vaccine causes autism” According to judges in Milan Court there is a link between hexavalent vaccine and autism March 2012 September 2014
  63. 63. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 Italy, 2014 69
  64. 64. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 Google’s thermometer 70 0 10 20 30 40 50 60 70 80 90 100 jan 10 mar 10 may 10 july 10 sept 10 nov 10 jan 11 mar 11 may 11 july 11 sept 11 nov 11 jan 12 mar 12 may 12 july 12 sept 12 nov 12 jan 13 mar 13 may 13 july 13 sept 13 nov 13 jan 14 mar 14 may 14 july 14 sept 14 nov 14 jan 15 mar 15 may 15 july 15 sept 15 nov 15 RelativeSearchVolume(RSV) vaccine measles autism vaccines autism vaccine autism MMR autism vaccine measles mumps rubella autism Aquino, F., et al. The web and public confidence in MMR vaccination in Italy. Vaccine, 2017 Rimini’s court Milan’s court
  65. 65. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 Vaccination coverage, Italy 2009-2015 71 85 87 89 91 93 95 97 99 2009 2010 2011 2012 2013 2014 2015 Polio MMR % Data source: Ministry of Health - Italy
  66. 66. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 72 May 2016: enough is enough
  67. 67. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 Digital in Italy 30M active social media users on mobile 73
  68. 68. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 April 2015 12.000 4.800 4.600 4.100 4.000 3.100 3.400 2.600 2.200
  69. 69. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 Echo chambers Comilva VaccinarSì “borderline”
  70. 70. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 Vaccine & Autism on YouTube in Italian 76 2007 2009 2010 2011 2012 2013 2014 2015 2016 2017 negative 1 4 18 5 18 28 27 46 96 147 positive 0 0 0 1 0 0 13 18 42 54 neutral 0 0 0 0 2 1 8 3 5 23 0 20 40 60 80 100 120 140 160 n°ofvideos Donzelli G, et al. Misinformation on vaccination: A quantitative analysis of YouTube videos. Hum Vaccin Immunother. 2018
  71. 71. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 April 2015 12.000 4.800 4.600 4.100 4.000 3.100 3.400 2.600 2.200 June 2018 11.645 23.993 21.547 27.875 20.375 19.108 10.771 361.443 55.285
  72. 72. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016
  73. 73. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 Vaccination coverage, Italy 2009-2017 79Data source: Ministry of Health - Italy 85 87 89 91 93 95 97 99 2009 2010 2011 2012 2013 2014 2015 2016 2017 Polio MMR %
  74. 74. SItI–SezioneApulo-LucanaCorsoFADemergenzeInfetticeinSanitàPubblica-2016 pierluigi.lopalco@unipi.it www.adultievaccinati.it @PLopalcoPublic @PLopalco
  75. 75. How might technology help with adult immunisation? David Sinclair Director ILC-UK This event is kindly supported by Sanofi #ImmuTech
  76. 76. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. Technology and Adult Immunisation David Sinclair, International Longevity Centre – UK @ilcuk @sinclairda
  77. 77. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. The Policy Context
  78. 78. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change.
  79. 79. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. On the one hand
  80. 80. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. The role for new technologies  140 years ago– first two way phone call made  In 2000 – ½ world had never owned a phone  By 2007 ½ the world had a mobile phone  It took 75 years for telephones to reach 50 million users  It took 4 years for the internet to reach 50 million
  81. 81. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. On the other “Ten or 15 years ago I could fly to New York in three and a half hours on Concorde. In the Victorian age they built a railway in five years. There is a big divergence here”. Rory Cellan Jones
  82. 82. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. And companies are beginning to recognise the impact of ageing
  83. 83. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. The future is bright – how can these innovations help increase uptake of adult vaccination?  Using data better  Gamification  The Internet  The Internet of Things  The Sharing Economy  Artificial Intelligence and Robotics  Blockchain  Materials Science
  84. 84. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. Who has a wearble? We like competing with our friends The recent growth of relatively affordable wearable monitoring technology offers huge greater potential to support healthy ageing.
  85. 85. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. Competition with friends might encourage us to be healthier
  86. 86. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. As might financial rewards
  87. 87. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. But humans cheat (or maintain control?)
  88. 88. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. Apps, Apps everywhere
  89. 89. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. Apps, Apps, everywhere In August 2011, the UK Health Minister, Andrew Lansley called on health professionals, patients and app designers to “suggest ideas for health-related smartphone apps and information maps”.
  90. 90. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. The sharing economy http://www.birminghammail.co.uk/whats-on/food-drink-news/brum- chef-opens-indian-restaurant-7190927
  91. 91. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. More of this sort of thing?
  92. 92. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. More use of our data?  It may be possible to predict dementia based on our spending patterns.  Royal Free allowed DeepMind to have 1.6 million NHS records  Chinese Government put up online for free a dataset with 1 million to 2 million health records.
  93. 93. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change.  Every single resident was tracked; their activity on social networks, their purchases, their movements, their commutes – everything was uploaded to the AI’s database, which then made real-time decisions.  Traffic congestion, road accidents, and crime are all down.  It’s also wired up to everyone’s mobile phones, informing them of upcoming road traffic or adverse weather conditions in real-time.
  94. 94. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change.  New digital records have the potential to automatically generate lists that identify undervaccinated populations, determine which vaccines are overdue, and generate reminders for doctors and the public.  Nanotechnology could deliver new ways of delivering vaccines which address the fear of the needle (e.g. oral/nasal/Nanopatch)  A humanoid robot might distract us from the pain.  A ‘digital necklace’ or app could helping store our vaccination history.  Services like PatientsLikeMe allow patients share information about adult vaccination with their peers and with medical practitioners.  Real time information services similar to Google Flu Trends can highlight the immediate risk of vaccine preventable diseases.
  95. 95. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. It has taken us 20 years to get Electronic Patient Records (and counting) 1997: Government said they would “harness the enormous potential benefits of IT to support the drive for quality and efficiency in the NHS by: making patient records electronically available when they’re needed using the NHSnet and the Internet to bring patients quicker test results, on-line booking of appointments and up-to-date specialist advice…developing telemedicine to ensure specialist skills are available to all parts of the country”.
  96. 96. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. How can we better engage older people Only 60% of retired people agreed that technology “makes things better” Over half thought that technologies “fail when you need them most” (2)
  97. 97. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. How can we better engage older people “But how much smaller do we want a phone?” Some/many do want new technology but: “I don’t want to live in a smart- home – I’d rather be dead” Of more than 25,000 people questioned in a 2012 survey of attitudes in the European Union, 60 per cent thought robots that care for children, the elderly and the disabled should be banned outright; and 86 per cent said they would be uncomfortable with one caring for their children or parents
  98. 98. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. How can we engage with the ethical issues? Moral and ethical debates – cant afford to ignore them Must help older people choose technology when it is right for them (tagging/urine tests) Privacy
  99. 99. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change.  How do we ensure that new technology isn’t just a gimmick, or worse, a distraction from evidence based interventions?  How can new technologies tackle inequalities in access and uptake as opposed to increasing them?  How can we “win the hearts and minds” of citizens?  How can we ensure that regulation protects consumers but does not prevent innovation?  Should policymakers be looking for better evidence of effectiveness or regulation of “apps”, games, or other solutions?  Inclusive Design Might a European Accessibility Act help?  How can we tackle digital exclusion among older adults?  How can we ensure a greater innovation focus on adults.
  100. 100. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. David Sinclair Director International Longevity Centre - UK Davidsinclair@ilcuk.org.uk 02073400440 Twitter: @ilcuk and @sinclairda
  101. 101. Q&A This event is kindly supported by Sanofi #ImmuTech
  102. 102. Putting ourselves in the shoes of someone who isn’t vaccinated Why don’t adults get vaccinated? This event is kindly supported by Sanofi #ImmuTech
  103. 103. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. Why don’t adults get vaccinated? 1) Develop 4 Personas (10 minutes) 2) Consider why they might not be vaccinated (10 minutes) a) Man, 80, has not had a vaccination since he was a child b) Man, 65, not a native speaker. Ethnic minority c) Woman, 70, lives alone d) Woman, 55, freelance professional
  104. 104. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. The Playing Cards – your job  Playing Higher or lower, pt. I - Ideas for using technology  Playing Higher or lower, pt. 2 - Barriers to using technology  Playing higher or lower, pt. 3 - Policy and practical solutions to using technology
  105. 105. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. What should you write on your cards? On one card - one idea for using technology e.g. – A “bot” could be used to talk people through their worries about vaccination – Uber could deliver a nurse to your house so you could be vaccinated On one card – one barrier to using technology e.g. – People are fearful of “Fake News” and don’t trust online messaging – People don’t want their data shared On one card - one Policy and practical solutions to using technology e.g. – Good data protection regulation (GDPR?) – Legislation to ensure easier to use websites
  106. 106. The International Longevity Centre-UK is an independent, non-partisan think-tank dedicated to addressing issues of longevity, ageing and population change. David Sinclair Director International Longevity Centre - UK Davidsinclair@ilcuk.org.uk 02073400440 Twitter: @ilcuk and @sinclairda
  107. 107. Lunch This event is kindly supported by Sanofi #ImmuTech
  108. 108. Plan for the afternoon David Sinclair Director ILC-UK This event is kindly supported by Sanofi #ImmuTech
  109. 109. Playing Higher or lower, part 1 – Ideas for using technology This event is kindly supported by Sanofi #ImmuTech
  110. 110. Playing Higher or lower, part 2 – Barriers to using technology This event is kindly supported by Sanofi #ImmuTech
  111. 111. Playing Higher or lower, part 3 – Policy and practical solutions to using technology This event is kindly supported by Sanofi #ImmuTech
  112. 112. Feedback – ‘Why don’t adults get vaccinated?’ and ‘Higher and Lower’ This event is kindly supported by Sanofi #ImmuTech
  113. 113. Conclusion This event is kindly supported by Sanofi #ImmuTech
  114. 114. Bogdan Wenta MEP Group of the European People’s Party (Christian Democrats) Poland This event is kindly supported by Sanofi #ImmuTech
  115. 115. Julie Girling MEP Group of the European People’s Party (Christian Democrats) UK This event is kindly supported by Sanofi #ImmuTech
  116. 116. Reactions from the day This event is kindly supported by Sanofi #ImmuTech
  117. 117. Dr Wendy Yared Director Association of European Cancer Leagues This event is kindly supported by Sanofi #ImmuTech
  118. 118. www.europeancancerleagues.org www.cancercode.eu 4th Revision 2014 (1st developed in 1987) Financed by the European Commission The European Code Against Cancer focuses on actions that individual citizens can take to help prevent cancer. Successful cancer prevention requires these individual actions to be supported by governmental policies and actions. 1 Do not smoke. Do not use any form of tobacco. 2 Make your home smoke free. Support smoke-free policies in your workplace. 3 Take action to be a healthy body weight. 4 Be physically active in everyday life. Limit the time you spend sitting. 5 Have a healthy diet: • Eat plenty of whole grains, pulses, vegetables and fruits. • Limit high-calorie foods (foods high in sugar or fat) and avoid sugary drinks. • Avoid processed meat; limit red meat and foods high in salt. 6 If you drink alcohol of any type, limit your intake. Not drinking alcohol is better for cancer prevention.
  119. 119. www.europeancancerleagues.org www.cancercode.eu •www.cancercode.eu 4th Revision 2014 (1st developed in 1987) Financed by the European Commission 7 Avoid too much sun, especially for children. Use sun protection. Do not use sunbeds. 8 In the workplace, protect yourself against cancer-causing substances by following health and safety instructions. 9 Find out if you are exposed to radiation from naturally high radon levels in your home. Take action to reduce high radon levels. 10 For women: • Breastfeeding reduces the mother’s cancer risk. If you can, breastfeed your baby. • Hormone replacement therapy (HRT) increases the risk of certain cancers. Limit use of HRT. 11 Ensure your children take part in vaccination programmes for: • Hepatitis B (for newborns) • Human papillomavirus (HPV) (for girls). 12 Take part in organized cancer screening programmes for: • Bowel cancer (men and women) • Breast cancer (women) • Cervical cancer (women).
  120. 120. www.europeancancerleagues.org
  121. 121. www.europeancancerleagues.org
  122. 122. Lana Crnjac Interim CEO European Liver Patients’ Association This event is kindly supported by Sanofi #ImmuTech
  123. 123. Marius Tudor Project Manager European Public Health Alliance This event is kindly supported by Sanofi #ImmuTech
  124. 124. Next steps David Sinclair Director ILC-UK This event is kindly supported by Sanofi #ImmuTech

×